ArticlePDF Available

Abstract and Figures

Keeping pace with food demand and climate change requires continuous genetic improvement of crops that, in turn, relies on the availability of genetic resources. Access to these resources is complicated by the need to establish benefit-sharing arrangements when accessing and using such genetic resources.
Content may be subject to copyright.
430
comment
The Nagoya Protocol and historical collections
of plants
Keeping pace with food demand and climate change requires continuous genetic improvement of crops that,
in turn, relies on the availability of genetic resources. Access to these resources is complicated by the need to
establish benefit-sharing arrangements when accessing and using such genetic resources.
Brad Sherman and Robert James Henry
Benefit-sharing arrangements have
been a key part of recent efforts to
ensure that benefits that arise from
the use of genetic resources are shared more
equitably1,2. While these arrangements work
well for some plants, in other situations,
access to established genetic collections is
hindered or blocked by these requirements.
This particularly affects historical
collections, where the provenance and
origin of plants are unclear or unknown.
The fate of plants in historical collections
is important given that they may contain
valuable genetic material that is no longer
available insitu. In these cases, it is crucial
that researchers and breeders are able to
access and use this historical material
to develop new plants3. Solutions that
facilitate access and benefit sharing for these
historical species are urgently required.
The international regulation of plant
genetic resources changed dramatically in
1992 when the Convention on Biological
Diversity (CBD) introduced the principal
that states have sovereignty over the
biological resources located within their
borders4. This was in contrast to the
situation previously, where biological
resources were the ‘common heritage’ of
humankind and freely available for use
without restriction. One of the aims of the
CBD is to promote the conservation and
sustainable use of biodiversity as well
as the fair and equitable sharing of the
benefits arising from the utilization of
genetic resources.
The push towards a more equitable
sharing of benefits under the CBD took an
important turn when the Nagoya Protocol
came into effect in 2014 (ref. 5). The
protocol, which provides member states
with guidance on how the CBD is to be
implemented, reaffirms the sovereign rights
of states over their natural resources6. One
of the goals of the Nagoya Protocol is to
establish a standardized global framework
that governs how users of genetic resources
access and utilize such resources. It also
aims to ensure that any benefits derived
from that utilization are shared fairly and
equitably with the providers. The protocol
does this by requiring member states to
adopt measures which ensure that there is
prior informed consent from the authorities
and providers of biological material and
that benefit-sharing agreements are in
place between users and providers of
biological material.
Unlike some international legal
agreements which only apply in the country
where they are enacted, Nagoya regulates
behaviour outside of the countries where it
has been adopted. This is because countries
that have ratified the protocol are not only
under an obligation to ensure that biological
material used in the country is Nagoya
compliant, but are also required to ensure
that biological material imported into
the country was collected, used and/or
developed in compliance with the protocol.
Specifically, they are required to ensure
that biological material imported into
the country is accompanied by relevant
documentary evidence, including:
• access permits from the relevant
authorities
• prior informed consent from the
authorities and providers of biological
material
• benet-sharing agreements between users
and providers of biological material5
Because the protocol applies to people
who want to export material into a country
that has implemented the Nagoya Protocol,
this means that for a company in the USA
(which is neither a member of the CBD nor
Nagoya) to export biological material to
France (which has adopted Nagoya), they
will have to show that the biological material
is ‘Nagoya compliant’.
Historical plant
material
Annex 1 of
the Plant Treaty
Covered by special
international access
and benefit-sharing
instrument
Not covered by special
international access
and benefit-sharing
instrument
In the multilateral
system
Countries where Nagoya
is retrospective
Countries where Nagoya
is prospective
Non-state actors
Fig. 1 | Nagoya compliance for historical plant material. Historical collections may or may not be
covered by the FAO treaty. If not covered by the treaty, it becomes important to consider if the Nagoya
protocol is retrospective or prospective in the jurisdiction.
NATURE PLANTS | VOL 6 | MAY 2020 | 430–432 | www.nature.com/natureplants
431
comment
The global reach of Nagoya has been
extended by a number of non-state actors,
such as universities, herbaria and scientific
journals, who have made Nagoya compliance
a pre-condition of dealing with biological
materials. For example, even though the
USA is neither a party to the CBD nor a
signatory to the protocol, the University of
California (or parts thereof) has adopted
Nagoya as best practice when dealing with
biological resources. This means that for a
researcher in Queensland to export a plant
to a colleague at the University of California,
they need to be able to show that the plant
was Nagoya compliant. Similarly, a number
of scientific journals, such as Nature journals,
require contributors writing about biological
material to make these materials available to
readers without restriction or show that the
plants being studied were collected with the
necessary approvals, such as BMC journals.
What it means for historical material
to be Nagoya compliant
One of criticisms made of the CBD
access and benefit-sharing regimes is
that they create bureaucratic barriers
that hinder research. While this needs
to be addressed, we are concerned here
with a different problem that arises when
implementing Nagoya at the national level:
different countries have taken different
interpretations of what Nagoya requires.
While this has occurred in a number of
areas, we focus on an issue particularly
important for food security — namely,
the question of the temporal scope of the
protocol and its impact on our ability to
access historical plant collections (Fig. 1).
During the Nagoya Protocol negotiations,
there were differing opinions about whether
the protocol should be limited to material
collected after it came into force or whether
it should regulate material irrespective of
when it was collected. Because the parties
could not agree on the temporal scope
of Nagoya, the protocol leaves it up to
individual countries to decide whether the
law should be prospective or retrospective
when they implement the protocol into
their national law7,8.
One of the consequences of the gradual
adoption of Nagoya globally is that it’s
changing the way researchers work with
plant material9,10. While this is relatively
straightforward regarding material that
has been collected recently, the position is
more complicated with historical materials
(that is, material collected before the CBD
came into operation in 1992). In part, this is
because researchers working with historical
materials may find that the provenance
of the material is unknown or unclear:
there may be no information about where
and when the material was collected, who
the access provider was or whether it
was collected with permission. This lack
of information is important because the
CBD presupposes that researchers are able
to negotiate with the party who initially
provided the material. While this makes
sense under the CBD, which only applies to
material accessed after the laws came into
force, the shift from ‘access’ to ‘use’ that
occurred under Nagoya means this is now
much more problematic11,12.
In this situation, the following question
arises: what does it mean for a researcher
who utilizes material from a historical
collection to be ‘Nagoya compliant’? The
answer to this question will depend on
whether the material falls within the special
exception established by Article 4 of the
Nagoya Protocol.
Where the Article 4 exception applies
Article 4 of the Nagoya Protocol creates
an exception whereby certain plants are
taken outside of the remit of Nagoya to
be governed by the 2001 International
Treaty on Plant Genetic Resources (‘Plant
Treaty’) and its Standard Material Transfer
Agreement (SMTA). While it is clear that
plant material falling under Article 4 of
Nagoya will be governed by the Plant Treaty
rather than the Nagoya Protocol, what is less
clear is when this occurs. This is because
there are competing interpretations about
when the exception applies.
On one reading, the Article 4 exception
only applies to the 64 plants listed in
Annex 1 of the Plant Treaty. With these
materials, compliance with the SMTA
should suffice. This means that an
Australian researcher working on native
sorghum (which is listed in Annex 1)
obtained from an historical collection would
be Nagoya compliant if they can show the
material was acquired under the SMTA.
On another reading, the Article 4
exception also applies to those materials that
are part of the Plant Treaty’s multilateral
system rather than those merely listed in
Annex 1. This would extend beyond the
scope of Annex 1 material to include plants
placed in the multilateral system, such
as Consultative Group on International
Agricultural Research (CGIAR) collections.
Under this reading, where materials are part
of the multilateral system and supplied with
the SMTA, they would be Nagoya compliant.
Where the Article 4 exception does
not apply
Questions about Nagoya compliance also
arise when plant materials fall outside the
scope of Article 4 (Table 1). The question of
whether plants not covered by Article 4 are
Nagoya compliant will change depending on
whether the relevant domestic law applies
to historical collections. It may also change
when Nagoya compliance is required by a
non-state actor.
In implementing the Nagoya Protocol
into domestic law, a number of countries
have limited the operation of Nagoya to
genetic resources collected after the Protocol
came into force. This was the approach
adopted by the European Union (EU). As a
result, if someone is using historical material
in the EU, or if they are in a non-EU country
and want to export material to one of the EU
member states, as the material is outside the
remit of the EU–Nagoya law, it would not be
necessary for them to show that the material
was Nagoya compliant1315.
An alternative reading provides that
because the protocol is triggered whenever
genetic material is ‘utilized, this means
that it applies retrospectively to material
collected before the protocol or, indeed,
the CBD came into operation. If someone
was using material in, or wanted to
export material to, a country that had
Table 1 | 2017 Production of some
high-value crops not listed in Annex 1 of
the FAO treaty
Crop Global production
in 2017 (millions
of tons)
Soybean 352
Sugarcane 1,842
Grapes 74
Mangos, magosteens
and guavas 51
Coffee 9
Onions 98
Peanuts 47
Olives 21
Almonds 2
Walnuts 4
Chillies and peppers 36
Rubber 14
Tea 6
Cucumber 84
Peaches and nectarines 25
Lettuce and chicory 27
Cacao (chocolate) 5
Chestnuts 2
Hazelnuts 1
Crops in Table 1 are not listed in Annex 1 of the FAO treaty;
because of this, it may be very difficult to establish Nagoya
compliance for historical collections of these species. Other
crops for which similar data is not available, including oil palm
and cotton seed oil, can be accessed via ref. 21.
NATURE PLANTS | VOL 6 | MAY 2020 | 430–432 | www.nature.com/natureplants
432
comment
decided to extend the Nagoya access and
benefit-sharing scheme to include material
collected before the national law came
into effect (such as Norway16,17 or South
Africa18,19), the fate of material not covered
by Article 4 would depend on what the
local laws allowed. In the absence of a
due-diligence ‘defence’ allowing someone to
use historical material when they have made
reasonable efforts to locate the provider
of the genetic material, it may simply not
be possible for someone to plant genetic
material with unknown lineage and still be
Nagoya compliant.
A third situation where questions about
Nagoya compliance arise is when someone
is dealing with non-state actors who have
made Nagoya compliance a condition of
working with them. Because Nagoya is silent
regarding whether it applies to historical
materials, and because different countries
have responded to this silence differently,
it is not clear what Nagoya compliance
means in this context. Thus, when a journal
asks a potential author working with
historical material whether the material
they are writing about is Nagoya compliant,
it might be legitimate for them to reply:
which Nagoya?
Uncertainty about the scope and
operation of the Nagoya Protocol is a
problem that needs to be avoided. At best,
it might slow or hamper access to biological
materials. At worst, it might mean that
access is blocked completely. There are a
number of potential options that might be
adopted to avoid these problems.
One option is to revise Nagoya to
expressly deal with plants in historical
collections. Given the different approaches
taken by member countries to the question
of whether the protocol should apply to
historical material, it is unlikely that there
would be the consensus needed to amend
Nagoya in this way.
Another option, which was rejected at
the Plant Treaty’s Governing Body 2019
meeting, would be to broaden Annex 1 of
the Plant Treaty to include all crops. Given
that the interests of countries in this matter
differ greatly (for example, some countries
favour expanding the treaty while others
are opposed because it would mean a loss
of control over crops of national interest),
we are sceptical about the possibility of
there being an international agreement to
extend Annex 1 to include all plants in the
foreseeable future.
Yet another option would be to increase
the material that is part of the multilateral
system. This could be done by building
on previous work of the Plant Treaty’s
governing body to reach agreement with
institutions for their materials to become
part of the multilateral system. The
effectiveness of this solution would depend
on there being consensus, which there
currently isn’t, about when the Article 4
exception applies.
While these options would improve
access to historical collections, given
the fractured nature of the international
law-making community, it is highly unlikely
that any will be adopted, at least in the near
future. Given this, perhaps the best option is
for scientists, breeders, universities, journals,
research organizations, herbaria, seed banks,
funding bodies and other non-state actors to
develop a common understanding of what
Nagoya compliance means. Rather than
waiting for reform at the international level,
this option could be developed through
micro-level collaborative interaction and
partner engagement.
If adopted, a common and shared
understanding of what Nagoya compliance
means would increase legal certainty,
reduce costs and facilitate timely access to
biological material that is so important for
the breeding of new plants and food security.
In developing a shared understanding of
what Nagoya compliance means, it would be
important to decide whether the Article 4
exception comes into play when the material
is listed in Annex 1 of the Plant Treaty or
when the material forms part of the Plant
Treaty multilateral system. It would also
be useful to decide whether Nagoya was
retrospective and, if so, what could be done
where the provenance of an historical plant
was unknown. Where a historical plant is
used, it is important that benefits flow back
to origin communities. Given that it may not
be possible to identify the origin or provider
of some historical plants, one option might
be to utilize the Plant Treaty SMTA20,
which directs benefits to the third-party
beneficiary fund and thus indirectly to
the origin community. While these are
challenging issues, the stakes are too high
for us not to attempt to find a solution that
ensures ongoing access to the historical
collections that are so important for
food security.
Brad Sherman1,2 and
Robert James Henry  1,3 ✉
1ARC Centre of Excellence for Plant Success in
Nature and Agriculture, University of Queensland,
Brisbane, Queensland, Australia. 2Law School,
University of Queensland, Brisbane, Queensland,
Australia. 3Queensland Alliance for Agriculture
and Food Innovation, University of Queensland,
Brisbane, Queensland, Australia.
e-mail: robert.henry@uq.edu.au
Published online: 15 May 2020
https://doi.org/10.1038/s41477-020-0657-8
References
1. Henry, R. J. Curr. Opin. Plant Biol. (in the press).
2. Xiao, J. H. etal. Nature 384, 223–224 (1996).
3. Tsioumani, E. J. World Intellect. Prop. 21, 106–122 (2018).
4. Robinson, D. F. Biodiversity, Access and Benet-Sharing: Global
Case Studies (Taylor & Francis, 2015).
5. e Nagoya Protocol on Access to Genetic Resources and
the Fair and Equitable Sharing of Benets Arising from
eir Utilization to the Convention on Biological Diversity
(United Nations, 2011).
6. Morgera, E., Tsioumani, E. & Matthias, B. Unravelling the
Nagoya Protocol: A Commentary on the Nagoya Protocol on Access
and Benet-sharing to the Convention on Biological Diversity
(Brill, 2014).
7. Lassen, B. etal. e Two Worlds of Nagoya—ABS Legislation in
the EU and Provider Countries: Discrepancies and how to deal
with them (Public Eye and Natural Justice, 2016).
8. Nijar, G.-S., Loua, S. & Welch, E.-W. Int. Environ. Agreem.-P 17,
607–621 (2017).
9. Kursar, T. A. BioScience 61, 256–257 (2011).
10. Robinson, D. F. & von Braun, J. in New Challenges for the Nagoya
Protocol (eds Correa, C. & Seuba, X.) 377–403 (Springer, 2019).
11. von Braun, J. & Meienberg, F. Access or Utilisation—What Tr iggers
User Obligations? (Public Eye and Natural Justice, 2013).
12. von Braun, J. & Brack, D. BioRes. 7, 3 (2013).
13. e European Parliament and the Council of the European
Union. O. J. Eur. Union 150, 59–71 (2014).
14. Kamau, E. C. & Winter, G. LEAD 9, 106–126 (2013).
15. Greiber, T. Phytomedicine 53, 313–318 (2019).
16. Nature Diversity Act Ministry of the Environment https://www.
regjeringen.no/en/dokumenter/nature-diversity-act/id570549/
(2009).
17. Tvedt, M. W. & Fauchald, O. K. J. World Intellect. Prop. 14,
383–402 (2011).
18. SA Government. National Environmental Management:
Biodiversity Act Report No. 26436 (Government Gazette, 2004).
19. Jansen, L. in e Indigenous World 455–462 (2016).
20. Schaeer, V. Res. Policy 48, 103824 (2019).
21. FAOSTAT data https://doi.org/http://www.fao.org/faostat/
en/#data (FAO, 2020).
Author contributions
B.S. and R.J.H. conceived and conducted the study and
wrote the manuscript.
Competing interests
The authors declare no competing interests.
NATURE PLANTS | VOL 6 | MAY 2020 | 430–432 | www.nature.com/natureplants
... It is noteworthy that some major countries, like the United States of America (USA), are not parties to the Nagoya Protocol [6], but may still generally support the principles of ABS [7]. For example, the University of California was described to have adopted the Nagoya Protocol as best practice when dealing with biological resources [8]. ...
... For example, an assessment from Brazil states that Brazil would not have to share the benefits of coffee genetic resources that were introduced into the country before the Protocol came into force [40]. The European Union (EU) has also specifically excluded historical material when implementing the Nagoya Protocol [8]. ...
... The implementation of the Nagoya Protocol in the coffee sector reflects a commitment to ethical practices and acknowledgment of source communities for genetic resources, even by non-state actors, such as universities, herbaria, and scientific journals, who have made Nagoya compliance a pre-condition of dealing with biological materials [8]. This is specifically evident in the approaches of various coffee research institutions, including the Coffea Biological Resource Centre (BRC) in La Réunion, France, CATIE in Costa Rica, and the International conservation collection of Coffee varieties at the Zoological and Botanical Garden Wilhelma in Stuttgart, Germany [51,52]. ...
Article
Full-text available
The Nagoya Protocol on Access and Benefit-sharing (ABS) of the Convention on Biological Diversity (CBD) is a fundamental international agreement that plays a crucial role in the protection and equitable utilization of plant genetic resources. While this agreement is essential for conservation and sustainable use, it presents specific challenges to coffee research and industry. One major issue is the requirement to obtain prior informed consent (PIC) from the source country or community, which can be a complex and time-consuming process, especially in regions with limited governance capacity. Additionally, the mandates of this agreement necessitate benefit-sharing with the source community, a requirement that poses implementation challenges, particularly for small businesses or individual researchers. Despite these challenges, the importance of the Nagoya Protocol in the coffee sector cannot be overstated. It contributes significantly to the conservation of coffee genetic resources and the sustainable utilization of these resources, ensuring fair distribution of benefits. To address the complexities presented by this international framework, coffee researchers and industry need to engage proactively with source countries and communities. This includes developing clear and equitable benefit-sharing and implementing strategies for compliance. This article explores the impact of the Nagoya Protocol on the coffee industry, particularly emphasizing the need for balancing scientific investigation with the ethical considerations of resource sharing. It also discusses practical strategies for navigating the complexities of this agreement, including research focused on authenticity control and the challenges in conducting large-scale coffee studies. The conclusion underscores the potential for international collaboration, particularly through platforms like the International Coffee Organization (ICO), to harmonize research activities with the ethical imperatives of the Nagoya Protocol.
... However, as the economy develops rapidly and the population continues to grow, China's biogenetic resources are also facing enormous pressure to be conserved. Human activities such as land development, urban expansion, and industrial pollution have caused serious damage to the habitat of biogenetic resources, and the survival of many rare and endangered species is in a fragile condition [6]. In this context, the Chinese government attaches great importance to the protection of biological genetic resources and has formulated a series of regulations and policies aimed at strengthening the protection of biological resources and promoting their rational use and sustainable development. ...
... Through measures such as artificial breeding and habitat protection, more than 1000 individual giant salamanders have been successfully rescued and bred, effectively promoting the recovery of the giant salamander population and the protection of biodiversity [55]. Among the nine first-level variable scores of P7, the three indicator scores of X 1 , X 6 , and X 7 all reached a score of 0.8. By analyzing the circular, it was found that the policy content highlighted five aspects of policy requirements, namely the protection and management of key fishery resources, the development of fishery resource enhancement, conservation and restoration activities, scientific aquaculture, increased law enforcement, and organizational leadership, which suggests that the policy function of the circular is relatively stable, the content is scientific and reasonable, and the nature of the circular is comprehensive [56]. ...
Article
Full-text available
Biogenetic resources are the foundation of biodiversity and are of great significance to the sustainability of human society. The effective promotion of biogenetic resource conservation depends on the scientific formulation and implementation of relevant policies, so the quantitative evaluation of biogenetic resource conservation policies can provide decision support for the next step of policy formulation. Based on text analysis, social network analysis, and the construction of the PMC index model, this study selected 132 policy samples issued by the Chinese government in the field of biogenetic resources, established an evaluation system for China’s biogenetic resources policies, which contains 10 first-level indicators and 55 s-level indicators, and drew the PMC curve diagram accordingly to quantitatively evaluate China’s biogenetic resources policies. The results show that China’s biogenetic resources policies are generally at a good level, which can meet the current practical needs of biogenetic resources conservation, but there are problems such as the lack of policy forecasts in the relevant policy texts, the lack of flexible planning in the short and medium term, the lack of co-operation among the policy issuers, and the insufficient guidance of innovation. Based on the results, this article puts forward suggestions for improving China’s biogenetic resource conservation policies.
... This is the case when information regarding taxa is well-documented, in the public domain, and has been so for a prolonged period. There is ambiguity in the Nagoya Protocol regarding historical germplasm collections and information (Sherman and Henry 2020) for the ethical development of native Australian crops that can address the challenges described above is outside the scope of this review, but the issues identified above will act as a major obstacle to research and development activities and nationally consistent legislation and best practice guidelines to address the issues are urgently needed. ...
... Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization" , which aims to implement the access and benefits-sharing obligations of the Convention on Biological Diversity(Lee 2013, Leha et al. 2019, Sherman and Henry 2020, Fyfe et al. 2021).However, traditional knowledge and intellectual property regarding edible native plants currently lack comprehensive legal protection in Australia or may not be adequately protected by existing laws(Leha et al. 2019). Food is globally recognised as an intangible cultural heritage, eligible for special recognition and protection (Di Giovine and Brulotte 2016, Galanakis 2019). ...
Article
Full-text available
Australia has a diverse and unique native flora with thousands of edible plant taxa, many of which are wild relatives of important food crops. These have the potential to diversify and improve the sustainability of Australian farming systems. However, the current level of domestication and cultivation of Australian plants as food crops is extremely limited by global standards. This review examines the current status and potential for future de novo domestication and large-scale cultivation of Australian plants as food crops. This is done in the context of international new crop development and factors that impact the success or failure of such efforts. Our review finds considerable potential for native Australian plants to be developed as food crops, but the industry faces several significant challenges. The current industry focuses on niche food markets that are susceptible to oversupply. It also suffers from inconsistent quantity and quality of product, which is attributed to a reliance on wild harvesting and the cultivation of unimproved germplasm. More active cultivation is necessary for industry growth, but attempts have historically failed due to poorly adapted germplasm and a lack of agronomic information. The de novo domestication and large-scale cultivation of Australian plants as food crops will require an investment in publicly supported multidisciplinary research and development programmes. Research programmes must prioritize the exploration of plants throughout Australia and the collection and evaluation of germplasm. Programmes must also seek to engage relevant stakeholders, pursue participatory research models and provide appropriate engagement and benefit-sharing opportunities with Indigenous Australian communities.
... The current classification of palaeontological and archaeological remains as genetic resources is debatable because it is impossible to predict in advance whether these samples will contain DNA (Lob & Botigué 2022). Historical collections also need to be aware whether NP is retrospective or prospective for implementation, as the temporal scope of NP varies (Sherman & Henry 2020). Further complications will arise should ABS regulations be extended to biodiversity data, as currently discussed (see von Wettberg & Khoury 2022 for further details). ...
... McCluskey et al. 2017b, Prathapan et al. 2018, Staerk et al. 2018, Zimkus 2018, Hurtado-Ortiz et al. 2019, Boundy-Mills et al. 2020, Sherman & Henry 2020, Collins et al. 2021. NP has created difficulties to access genetic resources and obtain permits from signatory countries that still lack or are developing individual procedures for implementing the protocol(Prathapan et al. 2018). ...
Preprint
Full-text available
Biobanks are curated collections of biological samples that are preserved at the molecular level, usually frozen, along with associated data, and managed to high scientific standards. We conducted a 'landscape analysis'—based both on a community survey and a literature review—to determine commonalities, information gaps, and challenges in the various workflows of biodiversity and environmental biobanks. The survey was completed by 55 institutions from more than 20 countries. Its results were compared to other collection-based surveys and complemented by literature research in the areas of general biobank management, staffing, sample handling, storage, (cryo-/)preservation, policies, databases, and networking. We illustrate the strengths and weaknesses of biodiversity and environmental biobanks and provide some basic recommendations for improving biobank procedures. In general, we found that increased efforts are needed to standardise biobank workflows or individual workflow components. While general, organism-independent biobanking guidelines already exist, more detailed guidance documents to date mostly address only human biobanking, or a narrow range of biodiversity. We hope to start closing that gap by providing an overview of current protocols and practices in biodiversity and environmental biobanking in form of a handbook, to which the present work is directly related. The handbook is available open-access under https://doi.org/10.3897/ab.e101876.
... Prior to the CBD, biological resources were assumed to be a 'common heritage' of humankind and to be freely available for use without restriction' (Sherman and Henry, 2020). Benefit-sharing arrangements and access to plant genetic resources have been central tenets of recent efforts like the CBD, more recently the Nagoya Protocol to ensure that access can be gained and benefits that arise from the use of plant genetic resources are shared more equitably. ...
Conference Paper
Full-text available
Māori are the indigenous people of Aotearoa-New Zealand (NZ). In 1840 the Treaty of Waitangi was established between Māori and the Crown, thereby guaranteeing Māori undisturbed possession of taonga (treasured) species. There were many breaches of the Treaty of Waitangi, which resulted in the establishment of the Waitangi Tribunal to rectify those past breaches, and the resulting Settlements with Iwi (the tribal sovereign nations of Māori). One such report, WAI 262, known as the flora and fauna claim, asserts Māori sovereignty over taonga species: those endemic to NZ and of significance to Māori in both traditional and contemporary contexts. The WAI 262 report, alongside international agreements such as the Nagoya Protocol, create a moral and ethical context for authentic partnerships and benefit sharing between indigenous people and industry/science, including breeding and use of taonga plant species. This paper will be co-presented from both an indigenous and a science perspective, providing examples of how indigenous-science partnerships can create innovative opportunities for the international ornamentals industry, within the moral and ethical frameworks of international policies and commitments, when based on best practice principles. The examples include projects spanning several genera (e.g. Leptospermum, Gentianella, Syzygium, and Corynocarpus), illustrating increasing success for authentic partnerships between Māori and industry/science, including governance of data, benefit-sharing agreements, informed consent, and facilitated access.
... DataPLAN considers regulatory and legal considerations that arise during the creation of a DMP. For example, certain data types, such as international genomic resources and personal data, are subject to specific regulations and laws such as the Nagoya Protocol and the General Data Protection Regulation (GDPR) [97,98]. To assist users navigating these complexities, DataPLAN incorporates a warning system ( Figure 5, red) that is activated when a selected data type or format falls within the purview of these regulations. ...
Article
Full-text available
Research data management (RDM) combines a set of practices for the organization, storage and preservation of data from research projects. The RDM strategy of a project is usually formalized as a data management plan (DMP)—a document that sets out procedures to ensure data findability, accessibility, interoperability and reusability (FAIR-ness). Many aspects of RDM are standardized across disciplines so that data and metadata are reusable, but the components of DMPs in the plant sciences are often disconnected. The inability to reuse plant-specific DMP content across projects and funding sources requires additional time and effort to write unique DMPs for different settings. To address this issue, we developed DataPLAN—an open-source tool incorporating prewritten DMP content for the plant sciences that can be used online or offline to prepare multiple DMPs. The current version of DataPLAN supports Horizon 2020 and Horizon Europe projects, as well as projects funded by the German Research Foundation (DFG). Furthermore, DataPLAN offers the option for users to customize their own templates. Additional templates to accommodate other funding schemes will be added in the future. DataPLAN reduces the workload needed to create or update DMPs in the plant sciences by presenting standardized RDM practices optimized for different funding contexts.
... DataPLAN takes into account regulatory and legal considerations that arise during the creation of a DMP. For example, certain data types, such as international genomic resources and personnel data, are subject to specific regulations and laws such as the Nagoya protocol and General Data Protection Regulation (GDPR) [53,54]. To assist users navigating these complexities, DataPLAN incorporates a warning system (Figure 3, red) that is activated when a selected data type or format falls within the purview of these regulations. ...
Preprint
Full-text available
Research Data Management (RDM) is a system for the effective handling of research data that enables scientists to structure their research questions and ensure best practices throughout the data lifecycle, from acquisition, computation and annotation to data publication and re-use. Data management plans (DMPs) are documents that formally set out the RDM of a project and are required by many funding bodies. DMPs help to organize and structure RDM strategies, thus promoting data findability, accessibility, interoperability and reusability (FAIR). Although DMPs incorporate methods and standards that can be reused by different research projects, the standardization of DMP content is not as evident as the standardization of RDM practices and data/metadata. To address this issue in the plant sciences, we developed DataPLAN — a tool that combines a questionnaire with pre-written standardized responses. We wrapped the questionnaire in a serverless single-page web application that can then generate standardized responses from DMP templates. The current templates cater to plant research grant proposals for Horizon 2020, Horizon Europe and the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). In the future the range of templates will be extended to accommodate other funding schemes, thereby enabling more users to generate their own templates. The DataPLAN web application is open-source and does not require an internet connection. By utilizing DataPLAN, the workload associated with creating, updating, and adhering to DMPs is significantly reduced.
... The Nagoya Treaty has agreed with the need for prior informed consent and mutually agreed terms for access to biodiversity to be negotiated with indigenous people. This has created challenges in the utilization of historical collections 15 and digital sequence information such as DNA sequences. 16 ...
Article
Full-text available
Plant biodiversity is a key resource underpinning efforts to satisfy the food needs of growing human populations while coping with climate change. Crop wild relatives provide options for diversification and...
Article
Natural products (NPs) provide an outstanding source of new exciting scaffolds and pharmacophores in drug discovery. Historical evidence demonstrates that life in the ocean began around 3.7 billion years ago which is three times longer than terrestrial life and produces a far greater evolutionary diversity. Notably, out of 34 major animal phyla, 33 are present in the ocean while only 12 are present on land [Citation1]. There are currently 15 marine derived drugs on the EU and/or US pharmaceutical market. Five of these have been approved in the last four years (, ). Ten out of the fifteen are on the market for treatment of cancer, and a small number are approved for the treatment of viral infections, hypertriglyceridemia, and chronic pain. Notably, 38 marine NP inspired pharmaceutical agents are in clinical trials out of around 40,000 isolated marine NPs.
Article
Full-text available
Over the years, researchers in public institutions and universities have accessed genetic materials from a variety of sources, freely exchanged them with fellow researchers and institutions and shared their research results with foreign and local collaborators. The 2010 Nagoya Protocol regulating access to genetic resources is set to change this scenario. This treaty requires country parties to put in place enhanced ABS measures regulating access to their genetic resources and to provide for the sharing of benefits arising from their utilization. These measures include minimum access standards, mandatory prior informed consent of indigenous and local communities, compliance with the domestic laws or requirements of the provider country and monitoring the utilization of genetic resources. This is aimed at commercial research. Non-commercial public research which contributes to the conservation and sustainable use of biological diversity is encouraged, particularly in developing countries, through simplified measures. There are undoubtedly practical challenges in operationalizing this provision without impeding research in the sector most potentially affected by ABS measures. This article presents the results of a survey of the practices of such researchers in one developing country, namely Malaysia. It examines the potential implications for the national implementation of the Protocol. Given country specificities, this study highlights and shows the importance of increasing knowledge about existing practices for an efficient design and implementation by developing countries of a complex legislation such as the Nagoya ABS Protocol.
Article
Full-text available
In October 2010, the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising From Their Utilization (NP) was adopted at the Conference of the Parties (COP-10) of the Convention on Biological Diversity (CBD). The NP establishes rules on measures to be taken by user countries in the context of access and benefit sharing (ABS). The future success of ABS as embedded in CBD and the Nagoya Protocol depends on their implementation at a national level. The binding rules of CBD and NP have in common that they need to be transformed into national legal and political contexts to establish a functional system for ABS. This article addresses measures that are needed in the international regime to secure adoption and implementation of user-country measures which are compatible with provider-country legislation. It analyses one current example of user-country legislation: the recently adopted Norwegian legislation, for the purpose of finding options for and obstacles to implementing obligations in the CBD and the NP in national law and in actual practice. One part of the ABS challenge is that obligations in the CBD and the NP apply to states, whereas the actual users of genetic resources are mostly private or public enterprises: companies, universities or other institutions. Despite showing a promising start, far from all challenges of a functional ABS system are solved.
Article
The transfer of scientific material and data, which are scientific inputs, is fundamental to knowledge creation dynamics. This transfer is being controlled, more and more, by the use of Material Transfer Agreements (MTAs). Therefore, the effect of MTAs on the dynamic of knowledge creation is an important concern. The aim of this research is to characterise the restrictions imposed by MTAs, and their determinants. We consider MTA diversity based on a comprehensive analysis of the clauses included in 171 MTAs signed by two French universities. We show that the clauses included in MTAs depend on several factors such as kind of material involved, research field, patenting and collection of material. We find that the presence of an industry actor is not associated to more restrictions on publication and intellectual property. We propose a typology of MTAs corresponding to different transfer situations. We discuss the role of MTAs as collaborative tools and the influence of the legal, scientific, political and organisational context.
Chapter
The aim of the paper is to compare some of the recent trends in implementation of the Nagoya Protocol, shedding light on the emerging discrepancies above all between the European Union and other provider and user countries that have implementing legislation (Switzerland, Norway, South Africa and Namibia). We particularly focus on differences in the “trigger” for benefit-sharing, the treatment of traditional knowledge, and user compliance measures. It is the authors’ belief that the emerging implementation discrepancies will undermine legal certainty and erode the necessary trust among users and providers to uphold the Protocol’s grand bargain of facilitating access to genetic resources on the one hand, while ensuring appropriate legal recognition and benefit-sharing on the other. We argue that above all, what the Nagoya Protocol provides is a normative standard for the sourcing and utilization of genetic resources and associated Traditional Knowledge that users should adhere to without doing a “scoping” analysis of the various jurisdictions and their access and benefit-sharing systems. In the end, it will be on these principles that the media and broader public will judge companies and other users.
Article
Background: In 2014 the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization entered into force. The Protocol aims to further concretize and improve the implementation of the access and benefit-sharing (ABS) obligations already foreseen under the Convention on Biological Diversity (CBD) since 1993. The European Union has accepted the challenge to establish the necessary monitoring and compliance measures which are envisaged in the Nagoya Protocol. For this two ABS Regulations (Regulation (EU) No 511/2014 and Implementing Regulation (EU) 2015/1866) were adopted in the European Union. Hypothesis However, the EU ABS legislation “only” provides a framework of instruments which now need to be tried out and tested in real life. Results As this paper shows competent national authorities in the European Union, such as the one in Germany, currently face a number of practical challenges ranging from ABS awareness raising in numerous and very diverse sectors, to clarification of the highly disputed scope of the EU ABS legislation, to the development of effective, proportionate and dissuasive compliance checks. Conclusions The paper concludes that the implementation of ABS in general and the Nagoya Protocol in particular remain a highly complicated task influenced by rapid technological developments and a general lack of trust between countries as well as stakeholders.
Article
The concept of fair and equitable benefit-sharing emerged in the early 90s as a corollary to the principle of national sovereignty over natural and genetic resources. In the context of agricultural biodiversity use, it can be conceptualized in three ways: as a defensive tool to balance the injustices enshrined in the intellectual property rights system; as a development tool to reap part of the benefits of the emerging biodiversity market; and as an incentive, to reward and enable farmers' continued contribution to conservation. This article seeks to assess the potential of the concept in operationalizing fairness and equity in agricultural biodiversity governance, in an increasingly complex legal and policy landscape of conflicting rights and policies. It briefly explains its emergence in the context of the evolving principles of governance of agricultural biodiversity; and analyses the structure and application of the Multilateral System of Access and Benefit-sharing established by the International Treaty on Plant Genetic Resources for Food and Agriculture in the framework of intellectual property- and human rights-related processes. Identifying linkages, challenges and key lessons, which are useful for a wide range of processes within and beyond the international environmental law realm, it concludes that the concept falls short of its promises. It thus calls for imagining new dialogues and concepts to redefine the boundaries between what must remain in the public domain, what may be managed as a commons and what may be privatized.
Book
The Nagoya Protocol to the Convention on Biological Diversity (CBD) is rapidly receiving signatures and ratifications. Many countries are preparing to implement the protocol through national research permit systems and/or biodiversity laws. Yet there is still considerable confusion about how to implement the Protocol, regarding access and benefit-sharing (ABS) procedures, and minimal experience in many countries. This book seeks to remedy this gap in understanding by analysing a number of ABS case studies in light of the Nagoya Protocol. The case studies are wide-ranging, with examples of plants for medicinal, cosmetic, biotech and food products from or for development in Australia, North Africa, Madagascar, Switzerland, Thailand, USA and Oceania. These will encourage countries to develop national systems which maximise their benefits (both monetary and non-monetary) towards conservation and support for local communities that hold traditional knowledge. In addition, the author analyses new expectations raised by the Nagoya Protocol, such as the encouragement of the development of community protocols by indigenous and local communities. As a result, stakeholders and policy-makers will be able to learn the steps involved in establishing ABS agreements, issues that arise between stakeholders, and the types of benefits that might be realistic.